JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB184177

Anti-Cullin 5/CUL-5 antibody [EPR14725]

Be the first to review this product! Submit a review

|

(30 Publications)

Rabbit Recombinant Monoclonal Cullin 5/CUL-5 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 30 publications.

View Alternative Names

VACM1, CUL5, Cullin-5, CUL-5, Vasopressin-activated calcium-mobilizing receptor 1, VACM-1

2 Images
Western blot - Anti-Cullin 5/CUL-5 antibody [EPR14725] (AB184177)
  • WB

Supplier Data

Western blot - Anti-Cullin 5/CUL-5 antibody [EPR14725] (AB184177)

All lanes:

Western blot - Anti-Cullin 5/CUL-5 antibody [EPR14725] (ab184177) at 1/10000 dilution

Lane 1:

HeLa cell lysate at 20 µg

Lane 2:

MOLT-4 cell lysate at 20 µg

Lane 3:

T47-D cell lysate at 20 µg

Secondary

All lanes:

Peroxidase conjugated Goat anti-Rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 90 kDa

Observed band size: 80 kDa

false

Western blot - Anti-Cullin 5/CUL-5 antibody [EPR14725] (AB184177)
  • WB

Lab

Western blot - Anti-Cullin 5/CUL-5 antibody [EPR14725] (AB184177)

All lanes:

Western blot - Anti-Cullin 5/CUL-5 antibody [EPR14725] (ab184177) at 1/2000 dilution

Lane 1:

Human heart lysates at 15 µg

Lane 2:

Mouse heart lysates at 15 µg

Lane 3:

Rat heart lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 90 kDa

Observed band size: 90 kDa

false

  • Carrier free

    Anti-Cullin 5/CUL-5 antibody [EPR14725] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR14725

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human, Mouse

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Core component of multiple cullin-5-RING E3 ubiquitin-protein ligase complexes (ECS complexes, also named CRL5 complexes), which mediate the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed : 11384984, PubMed : 15601820, PubMed : 21199876, PubMed : 21980433, PubMed : 23897481, PubMed : 25505247, PubMed : 27910872, PubMed : 32200094, PubMed : 33268465, PubMed : 35512830, PubMed : 38418882). Acts a scaffold protein that contributes to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme (PubMed : 11384984, PubMed : 15601820, PubMed : 33268465). The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable SOCS box-containing substrate recognition component (PubMed : 11384984, PubMed : 15601820, PubMed : 33268465). Acts as a key regulator of neuron positioning during cortex development : component of various SOCS-containing ECS complexes, such as the ECS(SOCS7) complex, that regulate reelin signaling by mediating ubiquitination and degradation of DAB1 (By similarity). ECS(SOCS1) seems to direct ubiquitination of JAK2 (PubMed : 11384984). The ECS(SOCS2) complex mediates the ubiquitination and subsequent proteasomal degradation of phosphorylated EPOR and GHR (PubMed : 21980433, PubMed : 25505247). The ECS(SPSB3) complex catalyzes ubiquitination of nuclear CGAS (PubMed : 38418882). ECS(KLHDC1) complex is part of the DesCEND (destruction via C-end degrons) pathway and mediates ubiquitination and degradation of truncated SELENOS selenoprotein produced by failed UGA/Sec decoding, which ends with a glycine (PubMed : 32200094). The ECS(ASB9) complex mediates ubiquitination and degradation of CKB (PubMed : 33268465). As part of some ECS complex, promotes 'Lys-11'-linked ubiquitination and degradation of BTRC (PubMed : 27910872). As part of a multisubunit ECS complex, polyubiquitinates monoubiquitinated POLR2A (PubMed : 19920177). As part of the ECS(RAB40C) complex, mediates ANKRD28 ubiquitination and degradation, thereby inhibiting protein phosphatase 6 (PP6) complex activity and focal adhesion assembly during cell migration (PubMed : 35512830). As part of the ECS(RAB40A) complex, mediates RHOU 'Lys-48'-linked ubiquitination and degradation, thus inhibiting focal adhesion disassembly during cell migration (PubMed : 26598620). As part of the ECS(RAB40B) complex, mediates LIMA1/EPLIN and RAP2 ubiquitination, thereby regulating actin cytoskeleton dynamics and stress fiber formation during cell migration (PubMed : 33999101, PubMed : 35293963). The ECS(ASB7) complex acts a negative regulator of H3K9me3 histone mark by mediating ubiquitination and degradation of SUV39H1 (PubMed : 40440427). May form a cell surface vasopressin receptor (PubMed : 9037604).. (Microbial infection) Following infection by HIV-1 virus, CUL5 associates with HIV-1 Vif proteins and forms a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex) that catalyzes ubiquitination and degradation of APOBEC3F and APOBEC3G (PubMed : 16636053, PubMed : 22190037). The complex can also ubiquitinate APOBEC3H to some extent (PubMed : 37640699).. (Microbial infection) Seems to be involved in proteasomal degradation of p53/TP53 stimulated by adenovirus E1B-55 kDa protein.
See full target information CUL5

Publications (30)

Recent publications for all applications. Explore the full list and refine your search

Clinical science (London, England : 1979) 139: PubMed39866066

2025

Blockade of neddylation through targeted inhibition of DCN1 alleviates renal fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jin-Ling Huo,Wenjia Fu,Qi Feng,Shaokang Pan,Dongwei Liu,Zhangsuo Liu

Nature communications 15:10376 PubMed39658572

2024

Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshitaka Adachi,Seitaro Terakura,Masahide Osaki,Yusuke Okuno,Yoshitaka Sato,Ken Sagou,Yuki Takeuchi,Hirofumi Yokota,Kanae Imai,Peter Steinberger,Judith Leitner,Ryo Hanajiri,Makoto Murata,Hitoshi Kiyoi

Nature communications 15:10536 PubMed39627198

2024

CRL3 E3 ligase facilitates ubiquitin-mediated degradation of oncogenic SRX to suppress colorectal cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Zhu,Liangshan Li,Yuanyuan Chen,Yongfu Pan,Wenjuan Zhang,Lihui Li,Lili Cai,Xiaoxue Zhao,Hu Zhao,Shiwen Wang,Lijun Jia

The FEBS journal 291:4473-4488 PubMed38978293

2024

TRAF2 associates with cullin neddylation complex assembly.

Applications

Unspecified application

Species

Unspecified reactive species

Tiantian Wang,Qi Zhang,Yu Xu,Rong Yan,Yuting Pan,Ying Xuan,Mengzhen Shen,Xianzhi Chen,Hongyan Zhu,Xisong Ke,Yi Qu,Xue Zhang

iScience 27:109802 PubMed38746666

2024

Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders.

Applications

Unspecified application

Species

Unspecified reactive species

Anaïs Cornebois,Marie Sorbara,Margot Cristol,Emmanuelle Vigne,Pierre Cordelier,Klervi Desrumeaux,Nicolas Bery

Nature communications 15:3890 PubMed38719850

2024

The Shigella kinase effector OspG modulates host ubiquitin signaling to escape septin-cage entrapment.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Xian,Jiaqi Fu,Qinxin Zhang,Chuang Li,Yan-Bo Zhao,Zhiheng Tang,Yi Yuan,Ying Wang,Yan Zhou,Peter S Brzoic,Ning Zheng,Songying Ouyang,Zhao-Qing Luo,Xiaoyun Liu

Acta pharmaceutica Sinica. B 14:729-750 PubMed38322326

2024

Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agent.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Chen,Xianggang Mu,Lele Ding,Xi Wang,Fei Mao,Jinlian Wei,Qian Liu,Yixiang Xu,Shuaishuai Ni,Lijun Jia,Jian Li

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2305907 PubMed38126621

2023

NNMT/1-MNA Promote Cell-Cycle Progression of Breast Cancer by Targeting UBC12/Cullin-1-Mediated Degradation of P27 Proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Yilei Ma,Xucheng Huang,Yanzhong Wang,Yinjiao Lei,Jinwei Yu,Shaobo Yu,Yuzhen Gao,Jun Yang,Feng Zhao,Haitao Yu,Jin Zeng,Yadong Chu,Min Yang,Guoli Li,Xinyou Xie,Jun Zhang

iScience 26:108199 PubMed37965157

2023

Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Wang,Jing Huang,Ruoyang Zhang,Muzhi Zhang,Yu Guo,Yang Liu,Cong Li,Wei Wang,Sun Ying,Jie Liu,Chen Wang

Nature chemical biology 19:1513-1523 PubMed37653169

2023

Activity-based profiling of cullin-RING E3 networks by conformation-specific probes.

Applications

Unspecified application

Species

Unspecified reactive species

Lukas T Henneberg,Jaspal Singh,David M Duda,Kheewoong Baek,David Yanishevski,Peter J Murray,Matthias Mann,Sachdev S Sidhu,Brenda A Schulman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com